✦ LIBER ✦

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

✍ Scribed by Juan Uriz; Pere Ginès; Andrés Cárdenas; Pau Sort; Wladimiro Jiménez; Juan Manuel Salmerón; Ramón Bataller; Antoni Mas; Miquel Navasa; Vicente Arroyo; Juan Rodés

Book ID: 119525614
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 612 KB
Volume: 33
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)80158-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Terlipressin therapy with and without al

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

✍ Rolando Ortega; Pere Ginès; Juan Uriz; Andrés Cárdenas; Blas Calahorra; Dara De 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Terlipressin therapy with and without al

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study

✍ Ortega, R 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Effects of terlipressin administration w

Effects of terlipressin administration with and without albumin in hepatorenal syndrome (HRS). A phase II study

✍ R. Ortega; P. Gines; J. Uriz; B. Calahorra; A. Cardenas; D. De Las Heras; M. Gue 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Predictors of response to therapy with t

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

✍ André Nazar; Gustavo Henrique Pereira; Mónica Guevara; Marta Martín-Llahi; Marie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

OC-29 Terlipressin and albumin vs midodr

OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F.

✍ M. Cavallin; M. Merli; S. Fasolato; P. Toniutto; F. Salerno; M. Bernardi; C. Col 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Effects of terlipressin administration w

Effects of terlipressin administration with and without albumin in hepatorenal syndrome (hrs). A phase-II study: Pere Gines, Rolando Ortega, Juan Uriz, Blas Calahorra, Andres Cardenas, Dara De Las Heras, Wladimiro Jimenez, Juan Salmeron, Vicente Arroyo, Juan Rodes, Liver Unit Hospital Clinic, Barcelona Spain

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB